Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,002 GBX | -0.50% | +2.35% | +11.91% |
05-03 | Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy | MT |
05-03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
Sales 2024 * | 2.99B 237B | Sales 2025 * | 3.09B 245B | Capitalization | 5.6B 445B |
---|---|---|---|---|---|
Net income 2024 * | 414M 32.88B | Net income 2025 * | 451M 35.82B | EV / Sales 2024 * | 2.16 x |
Net Debt 2024 * | 852M 67.7B | Net Debt 2025 * | 607M 48.19B | EV / Sales 2025 * | 2.01 x |
P/E ratio 2024 * |
13.8
x | P/E ratio 2025 * |
12.6
x | Employees | 9,100 |
Yield 2024 * |
2.82% | Yield 2025 * |
2.99% | Free-Float | 65.55% |
Latest transcript on Hikma Pharmaceuticals PLC
1 day | -0.25% | ||
1 week | +2.35% | ||
Current month | +4.05% | ||
1 month | +10.79% | ||
3 months | +1.88% | ||
6 months | +14.40% | ||
Current year | +11.91% |
Managers | Title | Age | Since |
---|---|---|---|
Riad Mishlawi
CEO | Chief Executive Officer | 60 | 31/12/89 |
Khalid Nabilsi
DFI | Director of Finance/CFO | 52 | 31/12/00 |
Said Darwazah
CHM | Chairman | 67 | 31/12/80 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Hurt
BRD | Director/Board Member | 66 | 30/04/20 |
Nina Henderson
BRD | Director/Board Member | 72 | 30/09/16 |
Victoria Hull
BRD | Director/Board Member | 62 | 31/10/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 1,083 M€ | +3.92% | ||
0.25% | 3 M€ | +9.95% | - | |
0.20% | 11 M€ | +0.83% | - |
Date | Price | Change | Volume |
---|---|---|---|
14/05/24 | 2,002 | -0.50% | 169 316 |
13/05/24 | 2,012 | +0.90% | 306,738 |
10/05/24 | 1,994 | +0.66% | 215,582 |
09/05/24 | 1,981 | +0.41% | 427,675 |
08/05/24 | 1,973 | +0.87% | 385,812 |
Delayed Quote London S.E., May 14, 2024 at 04:35 pm
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.91% | 5.6B | |
+29.82% | 682B | |
+30.35% | 586B | |
-3.74% | 364B | |
+17.49% | 327B | |
+3.52% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+7.34% | 165B |
- Stock Market
- Equities
- HIK Stock